Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
What You Missed On Wall Street On Thursday » 16:24
06/23/22
06/23
16:24
06/23/22
16:24
ACN

Accenture

$285.99 /

-0.98 (-0.34%)

, RDUS

Radius Health

$10.84 /

+1.945 (+21.87%)

, MO

Altria Group

$42.50 /

+1.02 (+2.46%)

, NVAX

Novavax

$51.80 /

+6.305 (+13.86%)

, MRNA

Moderna

$143.44 /

+7.395 (+5.44%)

, EBAY

eBay

$42.97 /

-0.14 (-0.32%)

, SNOW

Snowflake

$143.06 /

+15.715 (+12.34%)

, LUV

Southwest

$35.93 /

+0.23 (+0.64%)

, AYI

Acuity Brands

$146.38 /

-8.64 (-5.57%)

, MARA

Marathon Digital

$7.04 /

+0.285 (+4.22%)

, BTC

Bitcoin

/

+

, $BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

, UBER

Uber

$22.37 /

+0.88 (+4.09%)

, AVGO

Broadcom

$496.97 /

+0.71 (+0.14%)

, UAL

United Airlines

$35.82 /

-0.925 (-2.52%)

, CSCO

Cisco

$42.93 /

-0.655 (-1.50%)

, NKE

Nike

$108.01 /

+3.05 (+2.91%)

, NFLX

Netflix

$181.76 /

+2.83 (+1.58%)

, QURE

uniQure

$19.52 /

+4.14 (+26.92%)

, AMRS

Amyris

$2.15 /

+0.11 (+5.41%)

, CELH

Celsius Holdings

$63.84 /

+8.08 (+14.49%)

, PEP

PepsiCo

$164.14 /

+2.09 (+1.29%)

, XENE

Xenon Pharmaceuticals

$31.69 /

-3.04 (-8.75%)

, MULN

Mullen Automotive

$1.46 /

-0.15 (-9.35%)

, RAD

Rite Aid

$8.07 /

+1.345 (+20.01%)

, DRI

Darden

$115.64 /

+0.425 (+0.37%)

, KBH

KB Home

$28.50 /

+2.28 (+8.70%)

, FDS

FactSet

$388.96 /

+28.03 (+7.77%)

, RDHL

RedHill Biopharma

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$31.69 /

-3.04 (-8.75%)

UBER Uber
$22.37 /

+0.88 (+4.09%)

UAL United Airlines
$35.82 /

-0.925 (-2.52%)

SNOW Snowflake
$143.06 /

+15.715 (+12.34%)

RDUS Radius Health
$10.84 /

+1.945 (+21.87%)

RDHL RedHill Biopharma
/

+

RAD Rite Aid
$8.07 /

+1.345 (+20.01%)

QURE uniQure
$19.52 /

+4.14 (+26.92%)

PEP PepsiCo
$164.14 /

+2.09 (+1.29%)

NVAX Novavax
$51.80 /

+6.305 (+13.86%)

NKE Nike
$108.01 /

+3.05 (+2.91%)

NFLX Netflix
$181.76 /

+2.83 (+1.58%)

MULN Mullen Automotive
$1.46 /

-0.15 (-9.35%)

MRNA Moderna
$143.44 /

+7.395 (+5.44%)

MO Altria Group
$42.50 /

+1.02 (+2.46%)

MARA Marathon Digital
$7.04 /

+0.285 (+4.22%)

LUV Southwest
$35.93 /

+0.23 (+0.64%)

KBH KB Home
$28.50 /

+2.28 (+8.70%)

FDS FactSet
$388.96 /

+28.03 (+7.77%)

EBAY eBay
$42.97 /

-0.14 (-0.32%)

DRI Darden
$115.64 /

+0.425 (+0.37%)

CSCO Cisco
$42.93 /

-0.655 (-1.50%)

CELH Celsius Holdings
$63.84 /

+8.08 (+14.49%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

AYI Acuity Brands
$146.38 /

-8.64 (-5.57%)

AVGO Broadcom
$496.97 /

+0.71 (+0.14%)

AMRS Amyris
$2.15 /

+0.11 (+5.41%)

ACN Accenture
$285.99 /

-0.98 (-0.34%)

ACN Accenture
$285.99 /

-0.98 (-0.34%)

06/24/22 Piper Sandler
Accenture price target lowered to $305 from $368 at Piper Sandler
06/17/22 Deutsche Bank
Accenture price target lowered to $364 from $440 at Deutsche Bank
06/15/22 Cowen
Accenture price target lowered to $330 from $375 at Cowen
06/14/22 Morgan Stanley
Accenture price target lowered to $390 from $480 at Morgan Stanley
RDUS Radius Health
$10.84 /

+1.945 (+21.87%)

06/08/22 BofA
Radius Health upgraded to Neutral at BofA with bear thesis 'played out'
06/08/22 BofA
Radius Health upgraded to Neutral from Underperform at BofA
05/23/22 SVB Leerink
Radius Health initiated with a Market Perform at SVB Leerink
12/23/21 Stifel
New Radius' Tymlos label offers slight expansion potential, says Stifel
MO Altria Group
$42.50 /

+1.02 (+2.46%)

06/24/22 Morgan Stanley
Altria Group upgraded to Equal Weight from Underweight at Morgan Stanley
06/22/22 Goldman Sachs
Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs
06/22/22 Stifel
Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel
06/22/22 Jefferies
FDA lowered nicotine rule likely to take many years to implement, says Jefferies
NVAX Novavax
$51.80 /

+6.305 (+13.86%)

06/08/22 B. Riley
B. Riley sees front line status for Novavax vaccine as mRNA alternative
06/08/22 Cowen
Novavax positive advisory vote removes major overhang, says Cowen
06/08/22 Cantor Fitzgerald
Novavax price target raised to $168 from $146 at Cantor Fitzgerald
06/08/22 H.C. Wainwright
H.C. Wainwright expects 'significant market share' for Novavax vaccine
MRNA Moderna
$143.44 /

+7.395 (+5.44%)

06/14/22 Piper Sandler
Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax
06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
05/17/22 Piper Sandler
Moderna price target lowered to $214 from $348 at Piper Sandler
04/20/22 Piper Sandler
Piper says 'do not be fooled,' Arcturus Phase 3 shows strong vaccine efficacy
EBAY eBay
$42.97 /

-0.14 (-0.32%)

06/23/22 Morgan Stanley
eBay assumed with an Underweight at Morgan Stanley
06/09/22 Goldman Sachs
eBay downgraded to Sell from Neutral at Goldman Sachs
06/01/22 JMP Securities
eBay resumed with a Market Perform at JMP Securities
05/23/22 Bernstein
eBay initiated with a Market Perform at Bernstein
SNOW Snowflake
$143.06 /

+15.715 (+12.34%)

06/23/22 JPMorgan
Snowflake upgraded to Overweight from Neutral at JPMorgan
06/16/22 Piper Sandler
Snowflake has 'multi-billion growth potential,' says Piper Sandler
06/15/22 Canaccord
Snowflake upgraded to Buy at Canaccord following pullback
06/15/22 JPMorgan
Snowflake price target lowered to $165 from $200 at JPMorgan
LUV Southwest
$35.93 /

+0.23 (+0.64%)

06/23/22 Raymond James
Southwest upgraded to Strong Buy from Outperform at Raymond James
06/23/22 Raymond James
Southwest upgraded to Strong Buy from Outperform at Raymond James
06/22/22 Citi
Citi says this is not 2020 or 2008 for airline stocks
05/11/22 William Blair
ViaSat deal with Southwest 'solidifies industry dominance,' says William Blair
AYI Acuity Brands
$146.38 /

-8.64 (-5.57%)

06/23/22 William Blair
William Blair downgrades Acuity Brands after survey points to weaker demand
06/23/22 William Blair
Acuity Brands downgraded to Market Perform from Outperform at William Blair
06/17/22 Baird
Acuity Brands price target lowered to $188 from $210 at Baird
04/06/22 Wells Fargo
Acuity Brands price target lowered to $200 from $237 at Wells Fargo
MARA Marathon Digital
$7.04 /

+0.285 (+4.22%)

06/23/22 B. Riley
Marathon Digital downgraded to Neutral at B. Riley amid sharp decline in Bitcoin
06/23/22 B. Riley
Marathon Digital downgraded to Neutral from Buy at B. Riley
06/03/22 Chardan
Marathon Digital initiated with a Buy at Chardan
06/03/22 BTIG
Marathon Digital price target lowered to $16 from $50 at BTIG
BTC Bitcoin
/

+

06/13/22 Morgan Stanley
Ethereum weakening faster than bitcoin, says Morgan Stanley
06/07/22 Benchmark
Benchmark starts Canaan with Buy as 'indirect' bitcoin growth play
06/03/22 BTIG
Riot Blockchain price target lowered to $15 from $50 at BTIG
$BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

05/19/22 Goldman Sachs
Any drag on spending from lower cryptocurrency prices 'very small,' says Goldman
05/10/22 Morgan Stanley
$28,000 a technical level to watch for Bitcoin, says Morgan Stanley
UBER Uber
$22.37 /

+0.88 (+4.09%)

06/24/22 Wolfe Research
Uber price target lowered to $27 from $30 at Wolfe Research
06/16/22 Mizuho
Uber hits 'speed bump' in Massachusetts, says Mizuho
06/09/22 Goldman Sachs
Uber price target lowered to $45 from $55 at Goldman Sachs
06/08/22 Barclays
Barclays ups Uber target, says time to revisit long thesis
AVGO Broadcom
$496.97 /

+0.71 (+0.14%)

05/27/22 RBC Capital
VMware downgraded to Sector Perform from Outperform at RBC Capital
05/27/22 Mizuho
Broadcom price target raised to $725 from $700 at Mizuho
05/27/22 KeyBanc
Broadcom price target raised to $780 from $720 at KeyBanc
05/27/22 KeyBanc
VMware downgraded to Sector Weight from Overweight at KeyBanc
UAL United Airlines
$35.82 /

-0.925 (-2.52%)

06/23/22 Citi
Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List'
06/23/22 Raymond James
United Airlines price target lowered to $48 from $62 at Raymond James
05/06/22 Wolfe Research
United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
CSCO Cisco
$42.93 /

-0.655 (-1.50%)

05/20/22 Morgan Stanley
Cisco price target lowered to $46 from $59 at Morgan Stanley
05/19/22 Jefferies
Cisco price target lowered to $52 from $65 at Jefferies
05/19/22 Evercore ISI
Cisco price target lowered to $50 from $62 at Evercore ISI
05/19/22 BofA
Cisco price target lowered to $52 from $62 at BofA
NKE Nike
$108.01 /

+3.05 (+2.91%)

06/23/22 Cowen
Nike price target lowered to $133 from $139 at Cowen
06/23/22 Deutsche Bank
Nike price target lowered to $152 from $175 at Deutsche Bank
06/23/22 Credit Suisse
Nike price target lowered to $130 from $165 at Credit Suisse
06/22/22 BTIG
BTIG sees risk to Nike Q4 results and FY23 outlook
NFLX Netflix
$181.76 /

+2.83 (+1.58%)

06/23/22 BofA
Netflix price target lowered to $196 at BofA after streaming survey
06/21/22 Truist
Magnite well positioned to partner with Netflix, says Truist
06/21/22 Stifel
Netflix price target lowered to $240 from $300 at Stifel
06/14/22 Benchmark
Benchmark downgrades Netflix back to Sell after 'premature' upgrade
QURE uniQure
$19.52 /

+4.14 (+26.92%)

05/05/22 Stifel
uniQure price target lowered to $37 from $66 at Stifel
04/13/22 Truist
uniQure price target lowered to $51 from $90 at Truist
03/30/22 Chardan
uniQure price target lowered to $65 from $95 at Chardan
03/17/22 UBS
uniQure upgraded to Buy from Neutral at UBS
AMRS Amyris
$2.15 /

+0.11 (+5.41%)

05/25/22 Piper Sandler
Amyris initiated with a Neutral at Piper Sandler
05/13/22 HSBC
Amyris earnings selloff overdone, says HSBC
03/02/22 Cowen
Amyris assumed with an Outperform at Cowen
11/09/21 Roth Capital
Amyris price target lowered to $15 from $22 at Roth Capital
CELH Celsius Holdings
$63.84 /

+8.08 (+14.49%)

06/23/22 Stifel
PepsiCo/Bang announcement 'positive' for Monster, other brands, says Stifel
06/10/22 Stifel
Celsius Holdings price target raised to $77 from $67 at Stifel
05/11/22 B. Riley
Celsius Holdings price target lowered to $100 from $115 at B. Riley
05/11/22 Maxim
Celsius Holdings upgraded to Buy at Maxim after Q1 'triple beat'
PEP PepsiCo
$164.14 /

+2.09 (+1.29%)

06/21/22 UBS
PepsiCo price target lowered to $182 from $190 at UBS
04/27/22 Guggenheim
PepsiCo price target raised to $193 from $188 at Guggenheim
04/27/22 JPMorgan
PepsiCo price target raised to $186 from $183 at JPMorgan
XENE Xenon Pharmaceuticals
$31.69 /

-3.04 (-8.75%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
MULN Mullen Automotive
$1.46 /

-0.15 (-9.35%)

RAD Rite Aid
$8.07 /

+1.345 (+20.01%)

06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
04/21/22 Deutsche Bank
Deutsche Bank says 'just stop' with the Rite Aid takeover talk
04/18/22 Deutsche Bank
Rite Aid price target raised to $2 from $1 at Deutsche Bank
04/07/22 Deutsche Bank
Deutsche downgrades Rite Aid to Sell with $1 target into Q4 results
DRI Darden
$115.64 /

+0.425 (+0.37%)

06/24/22 Wedbush
Darden price target lowered to $122 from $140 at Wedbush
06/24/22 Piper Sandler
Darden price target lowered to $150 from $153 at Piper Sandler
06/24/22 Barclays
Darden price target lowered to $130 from $135 at Barclays
06/23/22 Stifel
Darden price target lowered to $135 from $160 at Stifel
KBH KB Home
$28.50 /

+2.28 (+8.70%)

06/23/22 Evercore ISI
KB Home price target raised to $50 from $46 at Evercore ISI
06/23/22 Wedbush
KB Home price target lowered to $60 from $73 at Wedbush
06/16/22 UBS
KB Home price target lowered to $45 from $66 at UBS
06/08/22 Barclays
KB Home price target lowered to $44 from $47 at Barclays
FDS FactSet
$388.96 /

+28.03 (+7.77%)

06/24/22 Barclays
FactSet price target lowered to $440 from $550 at Barclays
06/23/22 Stifel
Not clear why FactSet adjusted EPS guidance wasn't lifted, says Stifel
06/17/22 Deutsche Bank
FactSet price target lowered to $402 from $468 at Deutsche Bank
04/06/22 Deutsche Bank
FactSet price target raised to $468 from $453 at Deutsche Bank
RDHL RedHill Biopharma
/

+

12/01/21 BTIG
RedHill Biopharma price target lowered to $10 from $16 at BTIG
11/18/21
RedHill Biopharma files to sell common stock, no amount given
09/15/21 BTIG
RedHill Biopharma price target lowered to $16 from $24 at BTIG
09/15/21 H.C. Wainwright
RedHill Biopharma price target lowered to $21 from $23 at H.C. Wainwright
XENE Xenon Pharmaceuticals
$31.69 /

-3.04 (-8.75%)

UBER Uber
$22.37 /

+0.88 (+4.09%)

UAL United Airlines
$35.82 /

-0.925 (-2.52%)

SNOW Snowflake
$143.06 /

+15.715 (+12.34%)

RDUS Radius Health
$10.84 /

+1.945 (+21.87%)

RDHL RedHill Biopharma
/

+

RAD Rite Aid
$8.07 /

+1.345 (+20.01%)

QURE uniQure
$19.52 /

+4.14 (+26.92%)

PEP PepsiCo
$164.14 /

+2.09 (+1.29%)

NVAX Novavax
$51.80 /

+6.305 (+13.86%)

NKE Nike
$108.01 /

+3.05 (+2.91%)

NFLX Netflix
$181.76 /

+2.83 (+1.58%)

MRNA Moderna
$143.44 /

+7.395 (+5.44%)

MO Altria Group
$42.50 /

+1.02 (+2.46%)

MARA Marathon Digital
$7.04 /

+0.285 (+4.22%)

LUV Southwest
$35.93 /

+0.23 (+0.64%)

KBH KB Home
$28.50 /

+2.28 (+8.70%)

FDS FactSet
$388.96 /

+28.03 (+7.77%)

EBAY eBay
$42.97 /

-0.14 (-0.32%)

DRI Darden
$115.64 /

+0.425 (+0.37%)

CSCO Cisco
$42.93 /

-0.655 (-1.50%)

CELH Celsius Holdings
$63.84 /

+8.08 (+14.49%)

AYI Acuity Brands
$146.38 /

-8.64 (-5.57%)

AVGO Broadcom
$496.97 /

+0.71 (+0.14%)

ACN Accenture
$285.99 /

-0.98 (-0.34%)

  • 23
    Jun
  • 19
    Nov
  • 06
    Oct
  • 29
    Jul
UBER Uber
$22.37 /

+0.88 (+4.09%)

UAL United Airlines
$35.82 /

-0.925 (-2.52%)

SNOW Snowflake
$143.06 /

+15.715 (+12.34%)

RAD Rite Aid
$8.07 /

+1.345 (+20.01%)

PEP PepsiCo
$164.14 /

+2.09 (+1.29%)

NVAX Novavax
$51.80 /

+6.305 (+13.86%)

NKE Nike
$108.01 /

+3.05 (+2.91%)

NFLX Netflix
$181.76 /

+2.83 (+1.58%)

MULN Mullen Automotive
$1.46 /

-0.15 (-9.35%)

MRNA Moderna
$143.44 /

+7.395 (+5.44%)

MO Altria Group
$42.50 /

+1.02 (+2.46%)

MARA Marathon Digital
$7.04 /

+0.285 (+4.22%)

LUV Southwest
$35.93 /

+0.23 (+0.64%)

KBH KB Home
$28.50 /

+2.28 (+8.70%)

EBAY eBay
$42.97 /

-0.14 (-0.32%)

CSCO Cisco
$42.93 /

-0.655 (-1.50%)

BTC Bitcoin
/

+

AVGO Broadcom
$496.97 /

+0.71 (+0.14%)

XENE Xenon Pharmaceuticals
$31.69 /

-3.04 (-8.75%)

UBER Uber
$22.37 /

+0.88 (+4.09%)

UAL United Airlines
$35.82 /

-0.925 (-2.52%)

SNOW Snowflake
$143.06 /

+15.715 (+12.34%)

RDUS Radius Health
$10.84 /

+1.945 (+21.87%)

RAD Rite Aid
$8.07 /

+1.345 (+20.01%)

PEP PepsiCo
$164.14 /

+2.09 (+1.29%)

NVAX Novavax
$51.80 /

+6.305 (+13.86%)

NKE Nike
$108.01 /

+3.05 (+2.91%)

NFLX Netflix
$181.76 /

+2.83 (+1.58%)

MRNA Moderna
$143.44 /

+7.395 (+5.44%)

MO Altria Group
$42.50 /

+1.02 (+2.46%)

MARA Marathon Digital
$7.04 /

+0.285 (+4.22%)

LUV Southwest
$35.93 /

+0.23 (+0.64%)

FDS FactSet
$388.96 /

+28.03 (+7.77%)

EBAY eBay
$42.97 /

-0.14 (-0.32%)

DRI Darden
$115.64 /

+0.425 (+0.37%)

CSCO Cisco
$42.93 /

-0.655 (-1.50%)

CELH Celsius Holdings
$63.84 /

+8.08 (+14.49%)

BTC Bitcoin
/

+

AYI Acuity Brands
$146.38 /

-8.64 (-5.57%)

AVGO Broadcom
$496.97 /

+0.71 (+0.14%)

ACN Accenture
$285.99 /

-0.98 (-0.34%)

UBER Uber
$22.37 /

+0.88 (+4.09%)

UAL United Airlines
$35.82 /

-0.925 (-2.52%)

SNOW Snowflake
$143.06 /

+15.715 (+12.34%)

RDUS Radius Health
$10.84 /

+1.945 (+21.87%)

RAD Rite Aid
$8.07 /

+1.345 (+20.01%)

PEP PepsiCo
$164.14 /

+2.09 (+1.29%)

NVAX Novavax
$51.80 /

+6.305 (+13.86%)

NKE Nike
$108.01 /

+3.05 (+2.91%)

NFLX Netflix
$181.76 /

+2.83 (+1.58%)

MULN Mullen Automotive
$1.46 /

-0.15 (-9.35%)

MRNA Moderna
$143.44 /

+7.395 (+5.44%)

MO Altria Group
$42.50 /

+1.02 (+2.46%)

MARA Marathon Digital
$7.04 /

+0.285 (+4.22%)

LUV Southwest
$35.93 /

+0.23 (+0.64%)

KBH KB Home
$28.50 /

+2.28 (+8.70%)

FDS FactSet
$388.96 /

+28.03 (+7.77%)

EBAY eBay
$42.97 /

-0.14 (-0.32%)

CSCO Cisco
$42.93 /

-0.655 (-1.50%)

CELH Celsius Holdings
$63.84 /

+8.08 (+14.49%)

AVGO Broadcom
$496.97 /

+0.71 (+0.14%)

AMRS Amyris
$2.15 /

+0.11 (+5.41%)

ACN Accenture
$285.99 /

-0.98 (-0.34%)

On The Fly
What You Missed On Wall Street This Morning » 12:23
06/23/22
06/23
12:23
06/23/22
12:23
MO

Altria Group

$41.56 /

+0.075 (+0.18%)

, ACN

Accenture

$282.85 /

-4.12 (-1.44%)

, DRI

Darden

$114.93 /

-0.28 (-0.24%)

, KBH

KB Home

$28.54 /

+2.32 (+8.85%)

, RDUS

Radius Health

$10.16 /

+1.265 (+14.22%)

, EBAY

eBay

$42.44 /

-0.67 (-1.55%)

, SNOW

Snowflake

$138.16 /

+10.82 (+8.50%)

, LUV

Southwest

$34.94 /

-0.76 (-2.13%)

, AYI

Acuity Brands

$143.23 /

-11.79 (-7.61%)

, MARA

Marathon Digital

$6.70 /

-0.05 (-0.74%)

, BTC

Bitcoin

/

+

, UBER

Uber

$21.79 /

+0.3 (+1.40%)

, AVGO

Broadcom

$493.32 /

-2.94 (-0.59%)

, VMW

VMware

$115.53 /

-1.685 (-1.44%)

, UAL

United Airlines

$35.03 /

-1.71 (-4.65%)

, TSLA

Tesla

$700.88 /

-7.12 (-1.01%)

, CSCO

Cisco

$43.07 /

-0.51 (-1.17%)

, QURE

uniQure

$18.59 /

+3.21 (+20.87%)

, AMRS

Amyris

$2.12 /

+0.085 (+4.18%)

, WE

WeWork

$5.91 /

+0.495 (+9.15%)

, XENE

Xenon Pharmaceuticals

$31.53 /

-3.2 (-9.21%)

, MULN

Mullen Automotive

$1.37 /

-0.235 (-14.64%)

, RAD

Rite Aid

$7.59 /

+0.87 (+12.95%)

, FDS

FactSet

$386.68 /

+25.75 (+7.13%)

, RDHL

RedHill Biopharma

/

+

, XPER

Xperi

$14.44 /

+0.24 (+1.69%)

, MEI

Methode Electronics

$36.99 /

-1.215 (-3.18%)

, $BTC

Bitcoin

/

+

, BITCOIN

Bitcoin

/

+

Get caught up quickly on…

ShowHide Related Items >><<
XPER Xperi
$14.44 /

+0.24 (+1.69%)

XENE Xenon Pharmaceuticals
$31.53 /

-3.2 (-9.21%)

WE WeWork
$5.91 /

+0.495 (+9.15%)

VMW VMware
$115.53 /

-1.685 (-1.44%)

UBER Uber
$21.79 /

+0.3 (+1.40%)

UAL United Airlines
$35.03 /

-1.71 (-4.65%)

TSLA Tesla
$700.88 /

-7.12 (-1.01%)

SNOW Snowflake
$138.16 /

+10.82 (+8.50%)

RDUS Radius Health
$10.16 /

+1.265 (+14.22%)

RDHL RedHill Biopharma
/

+

RAD Rite Aid
$7.59 /

+0.87 (+12.95%)

QURE uniQure
$18.59 /

+3.21 (+20.87%)

MULN Mullen Automotive
$1.37 /

-0.235 (-14.64%)

MO Altria Group
$41.56 /

+0.075 (+0.18%)

MEI Methode Electronics
$36.99 /

-1.215 (-3.18%)

MARA Marathon Digital
$6.70 /

-0.05 (-0.74%)

LUV Southwest
$34.94 /

-0.76 (-2.13%)

KBH KB Home
$28.54 /

+2.32 (+8.85%)

FDS FactSet
$386.68 /

+25.75 (+7.13%)

EBAY eBay
$42.44 /

-0.67 (-1.55%)

DRI Darden
$114.93 /

-0.28 (-0.24%)

CSCO Cisco
$43.07 /

-0.51 (-1.17%)

BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

AYI Acuity Brands
$143.23 /

-11.79 (-7.61%)

AVGO Broadcom
$493.32 /

-2.94 (-0.59%)

AMRS Amyris
$2.12 /

+0.085 (+4.18%)

ACN Accenture
$282.85 /

-4.12 (-1.44%)

MO Altria Group
$41.56 /

+0.075 (+0.18%)

06/22/22 Goldman Sachs
Altria selloff overdone on potential FDA action on JUUL, says Goldman Sachs
06/22/22 Stifel
Potential ban of JUUL vapor products 'clear negative' for Altria, says Stifel
06/22/22 Jefferies
FDA lowered nicotine rule likely to take many years to implement, says Jefferies
06/08/22 Morgan Stanley
Morgan Stanley downgrades Altria to Underweight on competition concerns
ACN Accenture
$282.85 /

-4.12 (-1.44%)

06/17/22 Deutsche Bank
Accenture price target lowered to $364 from $440 at Deutsche Bank
06/15/22 Cowen
Accenture price target lowered to $330 from $375 at Cowen
06/14/22 Morgan Stanley
Accenture price target lowered to $390 from $480 at Morgan Stanley
06/14/22 Baird
Accenture price target lowered to $340 from $378 at Baird
DRI Darden
$114.93 /

-0.28 (-0.24%)

06/22/22 Oppenheimer
Darden price target lowered to $155 from $175 at Oppenheimer
06/21/22 Baird
Darden price target lowered to $146 from $160 at Baird
06/17/22 UBS
Darden price target lowered to $155 from $172 at UBS
06/17/22 Barclays
Darden price target lowered to $135 from $143 at Barclays
KBH KB Home
$28.54 /

+2.32 (+8.85%)

06/23/22 Evercore ISI
KB Home price target raised to $50 from $46 at Evercore ISI
06/23/22 Wedbush
KB Home price target lowered to $60 from $73 at Wedbush
06/16/22 UBS
KB Home price target lowered to $45 from $66 at UBS
06/08/22 Barclays
KB Home price target lowered to $44 from $47 at Barclays
RDUS Radius Health
$10.16 /

+1.265 (+14.22%)

06/08/22 BofA
Radius Health upgraded to Neutral at BofA with bear thesis 'played out'
06/08/22 BofA
Radius Health upgraded to Neutral from Underperform at BofA
05/23/22 SVB Leerink
Radius Health initiated with a Market Perform at SVB Leerink
12/23/21 Stifel
New Radius' Tymlos label offers slight expansion potential, says Stifel
EBAY eBay
$42.44 /

-0.67 (-1.55%)

06/23/22 Morgan Stanley
eBay assumed with an Underweight at Morgan Stanley
06/09/22 Goldman Sachs
eBay downgraded to Sell from Neutral at Goldman Sachs
06/01/22 JMP Securities
eBay resumed with a Market Perform at JMP Securities
05/23/22 Bernstein
eBay initiated with a Market Perform at Bernstein
SNOW Snowflake
$138.16 /

+10.82 (+8.50%)

06/23/22 JPMorgan
Snowflake upgraded to Overweight from Neutral at JPMorgan
06/16/22 Piper Sandler
Snowflake has 'multi-billion growth potential,' says Piper Sandler
06/15/22 Canaccord
Snowflake upgraded to Buy at Canaccord following pullback
06/15/22 JPMorgan
Snowflake price target lowered to $165 from $200 at JPMorgan
LUV Southwest
$34.94 /

-0.76 (-2.13%)

06/23/22 Raymond James
Southwest upgraded to Strong Buy from Outperform at Raymond James
06/23/22 Raymond James
Southwest upgraded to Strong Buy from Outperform at Raymond James
06/22/22 Citi
Citi says this is not 2020 or 2008 for airline stocks
05/11/22 William Blair
ViaSat deal with Southwest 'solidifies industry dominance,' says William Blair
AYI Acuity Brands
$143.23 /

-11.79 (-7.61%)

06/23/22 William Blair
William Blair downgrades Acuity Brands after survey points to weaker demand
06/23/22 William Blair
Acuity Brands downgraded to Market Perform from Outperform at William Blair
06/17/22 Baird
Acuity Brands price target lowered to $188 from $210 at Baird
04/06/22 Wells Fargo
Acuity Brands price target lowered to $200 from $237 at Wells Fargo
MARA Marathon Digital
$6.70 /

-0.05 (-0.74%)

06/23/22 B. Riley
Marathon Digital downgraded to Neutral at B. Riley amid sharp decline in Bitcoin
06/23/22 B. Riley
Marathon Digital downgraded to Neutral from Buy at B. Riley
06/03/22 Chardan
Marathon Digital initiated with a Buy at Chardan
06/03/22 BTIG
Marathon Digital price target lowered to $16 from $50 at BTIG
BTC Bitcoin
/

+

06/13/22 Morgan Stanley
Ethereum weakening faster than bitcoin, says Morgan Stanley
06/07/22 Benchmark
Benchmark starts Canaan with Buy as 'indirect' bitcoin growth play
06/03/22 BTIG
Riot Blockchain price target lowered to $15 from $50 at BTIG
UBER Uber
$21.79 /

+0.3 (+1.40%)

06/16/22 Mizuho
Uber hits 'speed bump' in Massachusetts, says Mizuho
06/09/22 Goldman Sachs
Uber price target lowered to $45 from $55 at Goldman Sachs
06/08/22 Barclays
Barclays ups Uber target, says time to revisit long thesis
05/31/22 Jefferies
Uber price target lowered to $50 from $65 at Jefferies
AVGO Broadcom
$493.32 /

-2.94 (-0.59%)

05/27/22 RBC Capital
VMware downgraded to Sector Perform from Outperform at RBC Capital
05/27/22 Mizuho
Broadcom price target raised to $725 from $700 at Mizuho
05/27/22 KeyBanc
Broadcom price target raised to $780 from $720 at KeyBanc
05/27/22 KeyBanc
VMware downgraded to Sector Weight from Overweight at KeyBanc
VMW VMware
$115.53 /

-1.685 (-1.44%)

05/31/22 Deutsche Bank
VMware price target raised to $142.50 from $135 at Deutsche Bank
UAL United Airlines
$35.03 /

-1.71 (-4.65%)

06/23/22 Citi
Citi adds AutoZone, Thermo Fisher, Ionis to 'Focus List'
06/23/22 Raymond James
United Airlines price target lowered to $48 from $62 at Raymond James
05/06/22 Wolfe Research
United Airlines upgraded to Peer Perform from Underperform at Wolfe Research
TSLA Tesla
$700.88 /

-7.12 (-1.01%)

06/22/22 Morgan Stanley
Tesla price target lowered to $1,200 from $1,300 at Morgan Stanley
06/15/22 Mizuho
Mizuho likes three electric vehicle stocks into second half rebound
06/14/22 Morgan Stanley
Morgan Stanley says 'very prudent' to shift some Tesla production to Q3 from Q2
06/13/22 RBC Capital
RBC Capital upgrades Tesla to Outperform on near-term improvement, positioning
CSCO Cisco
$43.07 /

-0.51 (-1.17%)

05/20/22 Morgan Stanley
Cisco price target lowered to $46 from $59 at Morgan Stanley
05/19/22 Jefferies
Cisco price target lowered to $52 from $65 at Jefferies
05/19/22 Evercore ISI
Cisco price target lowered to $50 from $62 at Evercore ISI
05/19/22 BofA
Cisco price target lowered to $52 from $62 at BofA
QURE uniQure
$18.59 /

+3.21 (+20.87%)

05/05/22 Stifel
uniQure price target lowered to $37 from $66 at Stifel
04/13/22 Truist
uniQure price target lowered to $51 from $90 at Truist
03/30/22 Chardan
uniQure price target lowered to $65 from $95 at Chardan
03/17/22 UBS
uniQure upgraded to Buy from Neutral at UBS
AMRS Amyris
$2.12 /

+0.085 (+4.18%)

05/25/22 Piper Sandler
Amyris initiated with a Neutral at Piper Sandler
05/13/22 HSBC
Amyris earnings selloff overdone, says HSBC
03/02/22 Cowen
Amyris assumed with an Outperform at Cowen
11/09/21 Roth Capital
Amyris price target lowered to $15 from $22 at Roth Capital
WE WeWork
$5.91 /

+0.495 (+9.15%)

06/22/22 Credit Suisse
WeWork initiated with an Outperform at Credit Suisse
04/22/22 Mizuho
WeWork initiated with a Buy at Mizuho
04/18/22 Piper Sandler
Piper Sandler starts WeWork at Overweight, sees profitability coming sooner
04/18/22 Piper Sandler
WeWork initiated with an Overweight at Piper Sandler
XENE Xenon Pharmaceuticals
$31.53 /

-3.2 (-9.21%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
MULN Mullen Automotive
$1.37 /

-0.235 (-14.64%)

RAD Rite Aid
$7.59 /

+0.87 (+12.95%)

06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
04/21/22 Deutsche Bank
Deutsche Bank says 'just stop' with the Rite Aid takeover talk
04/18/22 Deutsche Bank
Rite Aid price target raised to $2 from $1 at Deutsche Bank
04/07/22 Deutsche Bank
Deutsche downgrades Rite Aid to Sell with $1 target into Q4 results
FDS FactSet
$386.68 /

+25.75 (+7.13%)

06/17/22 Deutsche Bank
FactSet price target lowered to $402 from $468 at Deutsche Bank
04/06/22 Deutsche Bank
FactSet price target raised to $468 from $453 at Deutsche Bank
03/29/22 Deutsche Bank
FactSet initiated with a Hold at Deutsche Bank
03/28/22 UBS
FactSet price target raised to $454 from $432 at UBS
RDHL RedHill Biopharma
/

+

12/01/21 BTIG
RedHill Biopharma price target lowered to $10 from $16 at BTIG
11/18/21
RedHill Biopharma files to sell common stock, no amount given
09/15/21 BTIG
RedHill Biopharma price target lowered to $16 from $24 at BTIG
09/15/21 H.C. Wainwright
RedHill Biopharma price target lowered to $21 from $23 at H.C. Wainwright
XPER Xperi
$14.44 /

+0.24 (+1.69%)

06/15/22 BWS Financial
Xperi adverse ruling not material to underlying business, says BWS Financial
01/03/22 BWS Financial
Xperi upgraded to Top Pick from Buy at BWS Financial
08/19/21 Maxim
Xperi initiated with a Buy at Maxim
MEI Methode Electronics
$36.99 /

-1.215 (-3.18%)

06/15/22 Baird
Methode Electronics price target lowered to $42 from $46 at Baird
01/20/22 Barrington
Methode Electronics initiated with a Market Perform at Barrington
$BTC Bitcoin
/

+

BITCOIN Bitcoin
/

+

05/19/22 Goldman Sachs
Any drag on spending from lower cryptocurrency prices 'very small,' says Goldman
05/10/22 Morgan Stanley
$28,000 a technical level to watch for Bitcoin, says Morgan Stanley
XPER Xperi
$14.44 /

+0.24 (+1.69%)

XENE Xenon Pharmaceuticals
$31.53 /

-3.2 (-9.21%)

WE WeWork
$5.91 /

+0.495 (+9.15%)

VMW VMware
$115.53 /

-1.685 (-1.44%)

UBER Uber
$21.79 /

+0.3 (+1.40%)

UAL United Airlines
$35.03 /

-1.71 (-4.65%)

TSLA Tesla
$700.88 /

-7.12 (-1.01%)

SNOW Snowflake
$138.16 /

+10.82 (+8.50%)

RDUS Radius Health
$10.16 /

+1.265 (+14.22%)

RDHL RedHill Biopharma
/

+

RAD Rite Aid
$7.59 /

+0.87 (+12.95%)

QURE uniQure
$18.59 /

+3.21 (+20.87%)

MO Altria Group
$41.56 /

+0.075 (+0.18%)

MEI Methode Electronics
$36.99 /

-1.215 (-3.18%)

MARA Marathon Digital
$6.70 /

-0.05 (-0.74%)

LUV Southwest
$34.94 /

-0.76 (-2.13%)

KBH KB Home
$28.54 /

+2.32 (+8.85%)

FDS FactSet
$386.68 /

+25.75 (+7.13%)

EBAY eBay
$42.44 /

-0.67 (-1.55%)

DRI Darden
$114.93 /

-0.28 (-0.24%)

CSCO Cisco
$43.07 /

-0.51 (-1.17%)

AYI Acuity Brands
$143.23 /

-11.79 (-7.61%)

AVGO Broadcom
$493.32 /

-2.94 (-0.59%)

ACN Accenture
$282.85 /

-4.12 (-1.44%)

  • 23
    Jun
  • 19
    Nov
  • 06
    Oct
  • 29
    Jul
WE WeWork
$5.91 /

+0.495 (+9.15%)

UBER Uber
$21.79 /

+0.3 (+1.40%)

UAL United Airlines
$35.03 /

-1.71 (-4.65%)

TSLA Tesla
$700.88 /

-7.12 (-1.01%)

SNOW Snowflake
$138.16 /

+10.82 (+8.50%)

RAD Rite Aid
$7.59 /

+0.87 (+12.95%)

MULN Mullen Automotive
$1.37 /

-0.235 (-14.64%)

MO Altria Group
$41.56 /

+0.075 (+0.18%)

MARA Marathon Digital
$6.70 /

-0.05 (-0.74%)

LUV Southwest
$34.94 /

-0.76 (-2.13%)

KBH KB Home
$28.54 /

+2.32 (+8.85%)

EBAY eBay
$42.44 /

-0.67 (-1.55%)

CSCO Cisco
$43.07 /

-0.51 (-1.17%)

BTC Bitcoin
/

+

AVGO Broadcom
$493.32 /

-2.94 (-0.59%)

XPER Xperi
$14.44 /

+0.24 (+1.69%)

WE WeWork
$5.91 /

+0.495 (+9.15%)

UBER Uber
$21.79 /

+0.3 (+1.40%)

UAL United Airlines
$35.03 /

-1.71 (-4.65%)

TSLA Tesla
$700.88 /

-7.12 (-1.01%)

SNOW Snowflake
$138.16 /

+10.82 (+8.50%)

RDUS Radius Health
$10.16 /

+1.265 (+14.22%)

RAD Rite Aid
$7.59 /

+0.87 (+12.95%)

MULN Mullen Automotive
$1.37 /

-0.235 (-14.64%)

MO Altria Group
$41.56 /

+0.075 (+0.18%)

MEI Methode Electronics
$36.99 /

-1.215 (-3.18%)

MARA Marathon Digital
$6.70 /

-0.05 (-0.74%)

LUV Southwest
$34.94 /

-0.76 (-2.13%)

KBH KB Home
$28.54 /

+2.32 (+8.85%)

FDS FactSet
$386.68 /

+25.75 (+7.13%)

EBAY eBay
$42.44 /

-0.67 (-1.55%)

DRI Darden
$114.93 /

-0.28 (-0.24%)

CSCO Cisco
$43.07 /

-0.51 (-1.17%)

BTC Bitcoin
/

+

AYI Acuity Brands
$143.23 /

-11.79 (-7.61%)

AVGO Broadcom
$493.32 /

-2.94 (-0.59%)

ACN Accenture
$282.85 /

-4.12 (-1.44%)

WE WeWork
$5.91 /

+0.495 (+9.15%)

UBER Uber
$21.79 /

+0.3 (+1.40%)

UAL United Airlines
$35.03 /

-1.71 (-4.65%)

TSLA Tesla
$700.88 /

-7.12 (-1.01%)

SNOW Snowflake
$138.16 /

+10.82 (+8.50%)

RDUS Radius Health
$10.16 /

+1.265 (+14.22%)

RAD Rite Aid
$7.59 /

+0.87 (+12.95%)

MULN Mullen Automotive
$1.37 /

-0.235 (-14.64%)

MO Altria Group
$41.56 /

+0.075 (+0.18%)

MARA Marathon Digital
$6.70 /

-0.05 (-0.74%)

LUV Southwest
$34.94 /

-0.76 (-2.13%)

KBH KB Home
$28.54 /

+2.32 (+8.85%)

FDS FactSet
$386.68 /

+25.75 (+7.13%)

EBAY eBay
$42.44 /

-0.67 (-1.55%)

CSCO Cisco
$43.07 /

-0.51 (-1.17%)

AVGO Broadcom
$493.32 /

-2.94 (-0.59%)

AMRS Amyris
$2.12 /

+0.085 (+4.18%)

ACN Accenture
$282.85 /

-4.12 (-1.44%)

On The Fly
Fly Intel: Pre-market Movers » 08:52
06/23/22
06/23
08:52
06/23/22
08:52
DRI

Darden

$115.20 /

+1.55 (+1.36%)

, RAD

Rite Aid

$6.72 /

+0.405 (+6.41%)

, APOG

Apogee Enterprises

$37.80 /

+0.19 (+0.51%)

, RDHL

RedHill Biopharma

/

+

, KBH

KB Home

$26.22 /

+0.62 (+2.42%)

, ACN

Accenture

$286.76 /

+4.06 (+1.44%)

, EBAY

eBay

$43.13 /

+0.83 (+1.96%)

, XENE

Xenon Pharmaceuticals

$34.68 /

+1.84 (+5.60%)

, AGCO

Agco

$106.24 /

-4.4 (-3.98%)

Check out this morning's…

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

RDHL RedHill Biopharma
/

+

RAD Rite Aid
$6.72 /

+0.405 (+6.41%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

EBAY eBay
$43.13 /

+0.83 (+1.96%)

DRI Darden
$115.20 /

+1.55 (+1.36%)

APOG Apogee Enterprises
$37.80 /

+0.19 (+0.51%)

AGCO Agco
$106.24 /

-4.4 (-3.98%)

ACN Accenture
$286.76 /

+4.06 (+1.44%)

DRI Darden
$115.20 /

+1.55 (+1.36%)

06/22/22 Oppenheimer
Darden price target lowered to $155 from $175 at Oppenheimer
06/21/22 Baird
Darden price target lowered to $146 from $160 at Baird
06/17/22 UBS
Darden price target lowered to $155 from $172 at UBS
06/17/22 Barclays
Darden price target lowered to $135 from $143 at Barclays
RAD Rite Aid
$6.72 /

+0.405 (+6.41%)

06/03/22 Deutsche Bank
Rite Aid price target raised to $4 from $2 at Deutsche Bank
04/21/22 Deutsche Bank
Deutsche Bank says 'just stop' with the Rite Aid takeover talk
04/18/22 Deutsche Bank
Rite Aid price target raised to $2 from $1 at Deutsche Bank
04/07/22 Deutsche Bank
Deutsche downgrades Rite Aid to Sell with $1 target into Q4 results
APOG Apogee Enterprises
$37.80 /

+0.19 (+0.51%)

04/08/22 Craig-Hallum
Apogee Enterprises downgraded to Hold from Buy at Craig-Hallum
04/08/22 Craig-Hallum
Apogee Enterprises downgraded to Hold from Buy at Craig-Hallum
12/22/21 DA Davidson
Apogee Enterprises price target raised to $50 from $37 at DA Davidson
11/18/21 Craig-Hallum
Apogee Enterprises price target raised to $54 from $48 at Craig-Hallum
RDHL RedHill Biopharma
/

+

12/01/21 BTIG
RedHill Biopharma price target lowered to $10 from $16 at BTIG
11/18/21
RedHill Biopharma files to sell common stock, no amount given
09/15/21 BTIG
RedHill Biopharma price target lowered to $16 from $24 at BTIG
09/15/21 H.C. Wainwright
RedHill Biopharma price target lowered to $21 from $23 at H.C. Wainwright
KBH KB Home
$26.22 /

+0.62 (+2.42%)

06/23/22 Evercore ISI
KB Home price target raised to $50 from $46 at Evercore ISI
06/23/22 Wedbush
KB Home price target lowered to $60 from $73 at Wedbush
06/16/22 UBS
KB Home price target lowered to $45 from $66 at UBS
06/08/22 Barclays
KB Home price target lowered to $44 from $47 at Barclays
ACN Accenture
$286.76 /

+4.06 (+1.44%)

06/17/22 Deutsche Bank
Accenture price target lowered to $364 from $440 at Deutsche Bank
06/15/22 Cowen
Accenture price target lowered to $330 from $375 at Cowen
06/14/22 Morgan Stanley
Accenture price target lowered to $390 from $480 at Morgan Stanley
06/14/22 Baird
Accenture price target lowered to $340 from $378 at Baird
EBAY eBay
$43.13 /

+0.83 (+1.96%)

06/23/22 Morgan Stanley
eBay assumed with an Underweight at Morgan Stanley
06/09/22 Goldman Sachs
eBay downgraded to Sell from Neutral at Goldman Sachs
06/01/22 JMP Securities
eBay resumed with a Market Perform at JMP Securities
05/23/22 Bernstein
eBay initiated with a Market Perform at Bernstein
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
AGCO Agco
$106.24 /

-4.4 (-3.98%)

06/23/22 Morgan Stanley
Agco downgraded to Equal Weight from Overweight at Morgan Stanley
06/10/22 Deutsche Bank
Agco price target lowered to $141 from $143 at Deutsche Bank
04/14/22 Deutsche Bank
Agco price target raised to $143 from $141 at Deutsche Bank
03/28/22 JPMorgan
JPMorgan ups Agco target, adds to Analyst Focus List
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

RDHL RedHill Biopharma
/

+

RAD Rite Aid
$6.72 /

+0.405 (+6.41%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

EBAY eBay
$43.13 /

+0.83 (+1.96%)

DRI Darden
$115.20 /

+1.55 (+1.36%)

APOG Apogee Enterprises
$37.80 /

+0.19 (+0.51%)

AGCO Agco
$106.24 /

-4.4 (-3.98%)

ACN Accenture
$286.76 /

+4.06 (+1.44%)

  • 23
    Jun
  • 19
    Nov
  • 06
    Oct
RAD Rite Aid
$6.72 /

+0.405 (+6.41%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

EBAY eBay
$43.13 /

+0.83 (+1.96%)

AGCO Agco
$106.24 /

-4.4 (-3.98%)

RAD Rite Aid
$6.72 /

+0.405 (+6.41%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

EBAY eBay
$43.13 /

+0.83 (+1.96%)

DRI Darden
$115.20 /

+1.55 (+1.36%)

ACN Accenture
$286.76 /

+4.06 (+1.44%)

RAD Rite Aid
$6.72 /

+0.405 (+6.41%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

EBAY eBay
$43.13 /

+0.83 (+1.96%)

ACN Accenture
$286.76 /

+4.06 (+1.44%)

Syndicate
Xenon Pharmaceuticals 7.89M share Spot Secondary priced at $30.50 » 06:23
06/23/22
06/23
06:23
06/23/22
06:23
XENE

Xenon Pharmaceuticals

$34.68 /

+1.84 (+5.60%)

The deal range was…

The deal range was $30.00-$31.00. Jefferies, JPMorgan, SVB Leerink and Stifel acted as joint book running managers for the offering.

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

  • 23
    Jun
  • 06
    Oct
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

Wednesday
On The Fly
Fly Intel: After-Hours Movers » 17:57
06/22/22
06/22
17:57
06/22/22
17:57
SCS

Steelcase

$10.44 /

+0.02 (+0.19%)

, WOR

Worthington

$40.40 /

-0.56 (-1.37%)

, KBH

KB Home

$26.22 /

+0.62 (+2.42%)

, FUL

H.B. Fuller

$61.45 /

+0.08 (+0.13%)

, APLT

Applied Therapeutics

$1.07 /

-0.01 (-0.93%)

, RMTI

Rockwell Medical

$1.28 /

-0.02 (-1.54%)

, XENE

Xenon Pharmaceuticals

$34.68 /

+1.84 (+5.60%)

Check out this evening's…

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

WOR Worthington
$40.40 /

-0.56 (-1.37%)

SCS Steelcase
$10.44 /

+0.02 (+0.19%)

RMTI Rockwell Medical
$1.28 /

-0.02 (-1.54%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

FUL H.B. Fuller
$61.45 /

+0.08 (+0.13%)

APLT Applied Therapeutics
$1.07 /

-0.01 (-0.93%)

SCS Steelcase
$10.44 /

+0.02 (+0.19%)

WOR Worthington
$40.40 /

-0.56 (-1.37%)

08/23/21 Seaport Global
Worthington initiated with a Neutral at Seaport Global
KBH KB Home
$26.22 /

+0.62 (+2.42%)

06/16/22 UBS
KB Home price target lowered to $45 from $66 at UBS
06/08/22 Barclays
KB Home price target lowered to $44 from $47 at Barclays
05/13/22 Wolfe Research
KB Home downgraded to Underperform from Peer Perform at Wolfe Research
04/13/22 JPMorgan
KB Home price target lowered to $39 from $49 at JPMorgan
FUL H.B. Fuller
$61.45 /

+0.08 (+0.13%)

04/18/22 Deutsche Bank
H.B. Fuller upgraded on 'significant valuation upside' at Deutsche Bank
04/18/22 Deutsche Bank
H.B. Fuller upgraded to Buy from Hold at Deutsche Bank
04/14/22 Baird
H.B. Fuller upgraded to Outperform at Baird after underperformance
04/14/22 Baird
H.B. Fuller upgraded to Outperform from Neutral at Baird
APLT Applied Therapeutics
$1.07 /

-0.01 (-0.93%)

04/13/22 Truist
Applied Therapeutics price target lowered to $6 from $85 at Truist
03/21/22 Barclays
Applied Therapeutics price target lowered to $2.50 from $7 at Barclays
01/05/22 Citi
Applied Therapeutics price target lowered to $30 from $38 at Citi
01/04/22 Goldman Sachs
Applied Therapeutics price target lowered to $3 from $10 at Goldman Sachs
RMTI Rockwell Medical
$1.28 /

-0.02 (-1.54%)

01/18/22 H.C. Wainwright
Rockwell Medical price target lowered to $3 from $5 at H.C. Wainwright
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

WOR Worthington
$40.40 /

-0.56 (-1.37%)

SCS Steelcase
$10.44 /

+0.02 (+0.19%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

FUL H.B. Fuller
$61.45 /

+0.08 (+0.13%)

APLT Applied Therapeutics
$1.07 /

-0.01 (-0.93%)

  • 23
    Jun
  • 06
    Oct
KBH KB Home
$26.22 /

+0.62 (+2.42%)

APLT Applied Therapeutics
$1.07 /

-0.01 (-0.93%)

WOR Worthington
$40.40 /

-0.56 (-1.37%)

SCS Steelcase
$10.44 /

+0.02 (+0.19%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

FUL H.B. Fuller
$61.45 /

+0.08 (+0.13%)

APLT Applied Therapeutics
$1.07 /

-0.01 (-0.93%)

KBH KB Home
$26.22 /

+0.62 (+2.42%)

FUL H.B. Fuller
$61.45 /

+0.08 (+0.13%)

Syndicate
Xenon Pharmaceuticals $250M Spot Secondary; price range $30.00-$31.00 » 16:20
06/22/22
06/22
16:20
06/22/22
16:20
XENE

Xenon Pharmaceuticals

$34.68 /

+1.84 (+5.60%)

Jefferies, JPMorgan, SVB…

Jefferies, JPMorgan, SVB Leerink and Stifel are acting as joint book running managers for the offering.

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$34.68 /

+1.84 (+5.60%)

  • 06
    Oct
Syndicate
Xenon Pharmaceuticals announces common stock offering » 16:08
06/22/22
06/22
16:08
06/22/22
16:08
XENE

Xenon Pharmaceuticals

$34.46 /

+1.62 (+4.93%)

Xenon Pharmaceuticals…

Xenon Pharmaceuticals announced that it has commenced an underwritten public offering of its common shares and, in lieu of common shares to certain investors that so choose, pre-funded warrants to purchase common shares, pursuant to its existing shelf registration statement. Jefferies, J.P. Morgan, SVB Securities and Stifel are acting as joint book-running managers for the offering.

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.46 /

+1.62 (+4.93%)

XENE Xenon Pharmaceuticals
$34.46 /

+1.62 (+4.93%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$34.46 /

+1.62 (+4.93%)

  • 06
    Oct
Hot Stocks
Xenon provides update on additional data from XEN1101 program » 16:03
06/22/22
06/22
16:03
06/22/22
16:03
XENE

Xenon Pharmaceuticals

$34.45 /

+1.61 (+4.90%)

Xenon Pharmaceuticals…

Xenon Pharmaceuticals announced new, compelling efficacy data supporting the late-stage, Phase 3 development of XEN1101.Ian Mortimer, Xenon's President and Chief Executive Officer, stated, "We have generated additional efficacy data from sub-group analyses of our Phase 2b X-TOLE trial, which further support our Phase 3 development plans for XEN1101. A 'time course to efficacy' analysis shows that all doses of XEN1101 rapidly reduced the frequency of focal onset seizures within one week compared to placebo, suggesting that XEN1101 may offer a compelling and differentiated option for patients seeking to quickly reduce seizure frequency." Dr. Christopher Kenney, Xenon's Chief Medical Officer, commented, "Based on these Phase 2b efficacy data, we are including the secondary endpoint of 'Week 1 median percent change in seizure frequency' within the statistical hierarchy of the Phase 3 focal onset seizure trials to build upon the differentiated profile of XEN1101. Additionally, within our analysis of the open label extension population, we are seeing seizure frequency continuing to improve after the double-blind period with patients experiencing increased periods of seizure freedom. At the request of study investigators and based on the potential to continue to provide significant benefit to patients, we are extending the X-TOLE OLE from three to five years."

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$34.45 /

+1.61 (+4.90%)

XENE Xenon Pharmaceuticals
$34.45 /

+1.61 (+4.90%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$34.45 /

+1.61 (+4.90%)

  • 06
    Oct
Tuesday
Hot Stocks
Xenon Pharmaceuticals on track to initiate XEN1101 Phase 3 program in 2H22 » 07:07
06/21/22
06/21
07:07
06/21/22
07:07
XENE

Xenon Pharmaceuticals

$30.50 /

+1.74 (+6.05%)

Xenon Pharmaceuticals…

Xenon Pharmaceuticals announced next steps in its clinical program evaluating XEN1101 for the treatment of patients with focal onset seizures following the completion of an End-of-Phase 2 meeting with the U.S. Food & Drug Administration. The outcome of the EOP2 meeting supports the advancement of XEN1101 into Phase 3 clinical development, and Xenon remains on track to initiate the Phase 3 program in the second half of 2022. The EOP2 meeting was supported by nonclinical and clinical data, including results from the previously completed Phase 1 trials and the positive Phase 2b X-TOLE clinical trial evaluating XEN1101 in adult patients with FOS. The X-TOLE topline efficacy data demonstrated that the primary and secondary seizure reduction endpoints were statistically significant across all three dose groups, with p-values of less than0.001 for the 20 mg and 25 mg groups, and XEN1101 was generally well tolerated. Based on the EOP2 meeting, Xenon and the FDA aligned on key elements of the Phase 3 program to support a New Drug Application submission. Xenon plans to submit an NDA upon completion of the first XEN1101 Phase 3 clinical trial 'X-TOLE2', if successful, and use the existing data package from the Phase 2b X-TOLE clinical trial along with additional safety data from other clinical trials to meet regulatory requirements. Additionally, alignment was obtained with the FDA on key elements of a single Phase 3 clinical trial to pursue an additional epilepsy indication of primary generalized tonic clonic seizures. Xenon plans to initiate two identical Phase 3 clinical trials called X-TOLE2 and X-TOLE3, which are designed closely after the Phase 2b X-TOLE clinical trial. X-TOLE2 is expected to be initiated in the second half of 2022 followed by the initiation of X-TOLE3 and both studies will run in parallel. These multicenter, randomized, double-blind, placebo-controlled trials will evaluate the clinical efficacy and safety of XEN1101 administered as adjunctive treatment in patients with FOS. Approximately 360 patients will be randomized 1:1:1 for once-daily dosing of XEN1101, XEN1101 or placebo in each trial. Eligibility criteria include adults aged 18 to 75 years old taking one to three anti-seizure medications with a seizure frequency of greater than or equal to4 seizures per month at baseline. Patients will undergo an 8-week baseline period to assess seizure frequency and eligibility for randomization, followed by a 12-week double blind period. There is no titration period. The primary efficacy endpoint is the median percent change in monthly seizure frequency from baseline through the DBP of XEN1101 compared to placebo. Key secondary endpoints include the proportion of patients experiencing greater than or equal to50% reduction in seizure frequency from baseline for XEN1101 versus placebo, MPC at Week 1 compared to baseline to assess the rapidity of seizure reduction and the Patient Global Impression of Change at Week 12. On completion of the DBP in X-TOLE2 and X-TOLE3, eligible patients may enter an open-label extension study for up to three years. In addition, the ongoing X-TOLE open-label extension also continues to generate important long-term data for XEN1101 in FOS. About XEN1101 Phase 3 Plans in Primary Generalized Tonic Clonic Seizures: Following the initiation of X-TOLE2, Xenon plans to initiate a single Phase 3 clinical trial, called X-ACKT, to support potential regulatory submission in PGTCS. This multicenter, randomized, double-blind, placebo-controlled study will evaluate the clinical efficacy and safety of XEN1101 administered as adjunctive treatment in patients with PGTCS. Approximately 160 subjects will be randomized 1:1 for once-daily dosing of XEN1101 (25 mg) or placebo. Eligibility criteria include adults aged 18 to 75 years old taking one to three ASMs with a seizure frequency of greater than or equal to3 PGTCS over an 8-week baseline period. After the baseline period to assess seizure frequency and eligibility for randomization, patients will enter a 12-week DBP. There is no titration period. The primary efficacy endpoint is the MPC in monthly PGTCS frequency from baseline through the DBP of XEN1101 compared to placebo. Key secondary endpoints include the proportion of subjects experiencing greater than or equal to50% reduction in PGTCS frequency from baseline for XEN1101 versus placebo, seizure freedom and the PGI-C at Week 12. On completion of the DBP in X-ACKT, eligible patients may enter an open-label extension study for up to three year

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$30.50 /

+1.74 (+6.05%)

XENE Xenon Pharmaceuticals
$30.50 /

+1.74 (+6.05%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
XENE Xenon Pharmaceuticals
$30.50 /

+1.74 (+6.05%)

  • 06
    Oct
Over a month ago
Earnings
Xenon Pharmaceuticals reports Q1 EPS (35c), consensus (41c) » 16:17
05/10/22
05/10
16:17
05/10/22
16:17
XENE

Xenon Pharmaceuticals

$28.57 /

+3.18 (+12.52%)

Reports Q1 revenue…

Reports Q1 revenue $8.766M, consensus $8.7M. Ian Mortimer, Xenon's President and Chief Executive Officer stated, "We are excited by the progress across all of our clinical development programs, including screening the first patient in our recently initiated Phase 2 'X-NOVA' clinical trial to evaluate XEN1101 as a potential treatment for major depressive disorder. In addition, we are on track for our end-of-Phase 2 meeting with the FDA this quarter to support the initiation of the Phase 3 development plans for XEN1101 in epilepsy in the second half of this year. The Phase 3 'EPIK' pediatric study evaluating XEN496 as a treatment of KCNQ2-DEE is ongoing with anticipated completion in 2023."

ShowHide Related Items >><<
XENE Xenon Pharmaceuticals
$28.57 /

+3.18 (+12.52%)

XENE Xenon Pharmaceuticals
$28.57 /

+3.18 (+12.52%)

11/11/21 SVB Leerink
Xenon Pharmaceuticals price target raised to $40 from $34 at SVB Leerink
10/28/21 RBC Capital
Xenon Pharmaceuticals initiated with an Outperform at RBC Capital
10/06/21 Wedbush
Wedbush remains bullish on Xenon as financing gives firepower to advance XEN1101
10/04/21 Jefferies
Jefferies ups Xenon target to $50 after 'home run' epilepsy data
  • 06
    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.